Organisations across the UK are playing a vital role in innovating to develop a coronavirus vaccine. Officials are working closely with the Action for Global Health network and drawing on expertise from UK charities and organisations to shape global vaccine efforts. If UK-backed candidates for vaccines succeed, international efforts will be funded to ensure these vaccines scale up and support equitable access globally.

AstraZeneca has committed 300 million doses to low and middle-income countries if the Oxford vaccine is successful. The UK taxpayer's commitment through aid funding supports this work, ensuring equitable access via organisations like Gavi that vaccinate nearly half of the world's children and negotiate lower prices for vaccines.

The UK's commitment is linked to economic growth. With GNI expected to decline this year, we are working closely with the Treasury to understand forecasts and meet our 0.7% aid spending target. We are ensuring continued focus on aiding the most vulnerable by collaborating across government Departments.